Literature DB >> 31243341

Differential engagement of ORAI1 and TRPC1 in the induction of vimentin expression by different stimuli.

Teneale A Stewart1,2,3, Iman Azimi1,2,3,4, Daneth Marcial1, Amelia A Peters1, Silke B Chalmers1, Kunsala T D S Yapa1, Erik W Thompson3,5,6, Sarah J Roberts-Thomson1, Gregory R Monteith7,8,9.   

Abstract

The Ca2+ signal is essential in both hypoxia- and epidermal growth factor (EGF)-mediated epithelial to mesenchymal transition (EMT) in MDA-MB-468 breast cancer cells. This finding suggests that Ca2+-permeable ion channels participate in the induction of expression of some mesenchymal markers such as vimentin. However, the ion channels involved in vimentin expression induction have not been fully characterized. This work sought to define how differential modulation of the calcium signal effects the induction of vimentin and the Ca2+ influx pathways involved. We identified that the intracellular Ca2+ chelator EGTA-AM, cytochalasin D (a modulator of cytoskeletal dynamics and cell morphology), and the sarco/endoplasmic reticulum ATPase inhibitor thapsigargin are all inducers of vimentin in MDA-MB-468 breast cancer cells. EGTA-AM- and thapsigargin-mediated induction of vimentin expression in MDA-MB-468 cells involves store-operated Ca2+ entry, as evidenced by sensitivity to silencing of the molecular components of this pathway, STIM1 and ORAI1. In stark contrast, cytochalasin D-mediated vimentin induction was insensitive to silencing of ORAI1, despite sensitivity to silencing of its canonical activator the endoplasmic reticulum Ca2+ sensor STIM1. Cytochalasin D-mediated vimentin induction was, however, sensitive to silencing of another reported STIM1 target, TRPC1. Subsequent studies identified that EGTA-AM-induced vimentin expression also partially involved a TRPC1-dependent pathway. These studies define a complex interplay between vimentin expression in this model and the specific Ca2+-permeable ion channels involved. The complexity in the engagement of different Ca2+ influx pathways that regulate vimentin induction are opportunities but also potential challenges in targeting Ca2+ signaling to block EMT in cancer cells. Our findings further highlight the need to identify potential indispensable ion channels that can regulate induction of specific mesenchymal markers via different stimuli.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31243341     DOI: 10.1038/s41374-019-0280-3

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  42 in total

Review 1.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

Review 2.  Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression.

Authors:  Xin Ye; Robert A Weinberg
Journal:  Trends Cell Biol       Date:  2015-10-01       Impact factor: 20.808

Review 3.  Targeting EMT in cancer: opportunities for pharmacological intervention.

Authors:  Felicity M Davis; Teneale A Stewart; Erik W Thompson; Gregory R Monteith
Journal:  Trends Pharmacol Sci       Date:  2014-07-16       Impact factor: 14.819

4.  A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer.

Authors:  A Bonnomet; L Syne; A Brysse; E Feyereisen; E W Thompson; A Noël; J-M Foidart; P Birembaut; M Polette; C Gilles
Journal:  Oncogene       Date:  2011-11-28       Impact factor: 9.867

5.  Evidence for the presence of tetrodotoxin in a powder used in Haiti for zombification.

Authors:  C Benedek; L Rivier
Journal:  Toxicon       Date:  1989       Impact factor: 3.033

Review 6.  Novel functions of vimentin in cell adhesion, migration, and signaling.

Authors:  Johanna Ivaska; Hanna-Mari Pallari; Jonna Nevo; John E Eriksson
Journal:  Exp Cell Res       Date:  2007-04-14       Impact factor: 3.905

Review 7.  The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies.

Authors:  Brett G Hollier; Kurt Evans; Sendurai A Mani
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-02-26       Impact factor: 2.673

Review 8.  Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression.

Authors:  Caitlin D May; Nathalie Sphyris; Kurt W Evans; Steven J Werden; Wenjun Guo; Sendurai A Mani
Journal:  Breast Cancer Res       Date:  2011-02-08       Impact factor: 6.466

9.  EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.

Authors:  Anne-Pierre Morel; George W Hinkal; Clémence Thomas; Frédérique Fauvet; Stéphanie Courtois-Cox; Anne Wierinckx; Mojgan Devouassoux-Shisheboran; Isabelle Treilleux; Agnès Tissier; Baptiste Gras; Julie Pourchet; Isabelle Puisieux; Gareth J Browne; Douglas B Spicer; Joël Lachuer; Stéphane Ansieau; Alain Puisieux
Journal:  PLoS Genet       Date:  2012-05-24       Impact factor: 5.917

10.  Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent.

Authors:  F M Davis; I Azimi; R A Faville; A A Peters; K Jalink; J W Putney; G J Goodhill; E W Thompson; S J Roberts-Thomson; G R Monteith
Journal:  Oncogene       Date:  2013-05-20       Impact factor: 9.867

View more
  2 in total

Review 1.  Ca2+ Signalling and Hypoxia/Acidic Tumour Microenvironment Interplay in Tumour Progression.

Authors:  Madelaine Magalì Audero; Natalia Prevarskaya; Alessandra Fiorio Pla
Journal:  Int J Mol Sci       Date:  2022-07-02       Impact factor: 6.208

2.  Activation of the Ion Channel TRPV4 Induces Epithelial to Mesenchymal Transition in Breast Cancer Cells.

Authors:  Iman Azimi; Mélanie Robitaille; Kaela Armitage; Choon Leng So; Michael J G Milevskiy; Korinne Northwood; Huai Fang Lim; Erik W Thompson; Sarah J Roberts-Thomson; Gregory R Monteith
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.